Molecular biology and infection of hepatitis E virus

Frontiers in Microbiology

Volumn 7, Issue SEP, 2016, Pages

  Nan, Yuchen ^a,b   Zhang, Yan Jin ^b  

^a NORTHWEST A F UNIVERSITY   (China)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Hepatitis E virus; HEV; HEV biology; HEV infection; HEV vaccine; Viral proteins of HEV

Indexed keywords

CAPSID PROTEIN; CYSTEINE PROTEINASE; GENOMIC RNA; HELICASE; HEPATITIS E VACCINE; METHYLTRANSFERASE; STRUCTURAL PROTEIN; VIRAL PROTEIN;

GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; OPEN READING FRAME; PATHOGENESIS; PROTEIN PROTEIN INTERACTION; REVIEW; RUBELLA VIRUS; SEQUENCE ANALYSIS; TROPISM; VIRUS STRAIN;

EID: 84992690607     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.01419     Document Type: Review

References (270)

1. Abes, S., Moulton, H. M., Clair, P., Prevot, P., Youngblood, D. S., Wu, R. P., et al. (2006). Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents. J. Control. Release 116, 304-313. doi: 10.1016/j.jconrel.2006.09.011
2. Aggarwal, R., Shukla, R., Jameel, S., Agrawal, S., Puri, P., Gupta, V. K., et al. (2007). T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus. J. Viral Hepat. 14, 283-292. doi: 10.1111/j.1365-2893.2006.00796.x
3. Agrawal, S., Gupta, D., and Panda, S. K. (2001). The 3' end of hepatitis E virus (HEV) genome binds specifically to the viral RNA-dependent RNA polymerase (RdRp). Virology 282, 87-101. doi: 10.1006/viro.2000.0819
4. Aguiar, R. C., Takeyama, K., He, C., Kreinbrink, K., and Shipp, M. A. (2005). B-aggressive lymphoma family proteins have unique domains that modulate transcription and exhibit poly(ADP-ribose) polymerase activity. J. Biol. Chem. 280, 33756-33765. doi: 10.1074/jbc. M505408200
5. Ahmad, I., Holla, R. P., and Jameel, S. (2011). Molecular virology of hepatitis E virus. Virus Res. 161, 47-58. doi: 10.1016/j.virusres.2011.02.011
6. Allen, M. D., Buckle, A. M., Cordell, S. C., Lowe, J., and Bycroft, M. (2003). The crystal structure of AF1521 a protein from Archaeoglobus fulgidus with homology to the non-histone domain of macroH2A. J. Mol. Biol. 330, 503-511. doi: 10.1016/S0022-2836(03)00473-X
7. Amantana, A., Moulton, H. M., Cate, M. L., Reddy, M. T., Whitehead, T., Hassinger, J. N., et al. (2007). Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate. Bioconjug. Chem. 18, 1325-1331. doi: 10.1021/bc070060v
8. Anang, S., Subramani, C., Nair, V. P., Kaul, S., Kaushik, N., Sharma, C., et al. (2016). Identification of critical residues in hepatitis E virus macro domain involved in its interaction with viral methyltransferase and ORF3 proteins. Sci. Rep. 6, 25133. doi: 10.1038/srep25133
9. Angelov, D., Molla, A., Perche, P. Y., Hans, F., Cote, J., Khochbin, S., et al. (2003). The histone variant macroH2A interferes with transcription factor binding and SWI/SNF nucleosome remodeling. Mol. Cell 11, 1033-1041. doi: 10.1016/S1097-2765(03)00100-X
10. Ansari, I. H., Nanda, S. K., Durgapal, H., Agrawal, S., Mohanty, S. K., Gupta, D., et al. (2000). Cloning, sequencing, and expression of the hepatitis E virus (HEV) nonstructural open reading frame 1 (ORF1). J. Med. Virol. 60, 275-283. doi: 10.1002/(SICI)1096-9071(200003)60:3%3C275::AID-JMV5%3E3.0.CO;2-9
11. Anthony, K., Feng, L., Arechavala-Gomeza, V., Guglieri, M., Straub, V., Bushby, K., et al. (2012). Exon skipping quantification by quantitative reverse-transcription polymerase chain reaction in Duchenne muscular dystrophy patients treated with the antisense oligomer eteplirsen. Hum. Gene. Ther. Methods 23, 336-345. doi: 10.1089/hgtb.2012.117
12. Balayan, M. S., Andjaparidze, A. G., Savinskaya, S. S., Ketiladze, E. S., Braginsky, D. M., Savinov, A. P., et al. (1983). Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 20, 23-31. doi: 10.1159/000149370
13. Batts, W., Yun, S., Hedrick, R., and Winton, J. (2011). A novel member of the family Hepeviridae from cutthroat trout (Oncorhynchus clarkii). Virus Res. 158, 116-123. doi: 10.1016/j.virusres.2011.03.019
14. Baumann, S., Grob, P., Stuart, F., Pertlik, D., Ackermann, M., and Suter, M. (1998). Indirect immobilization of recombinant proteins to a solid phase using the albumin binding domain of streptococcal protein G and immobilized albumin. J. Immunol. Methods 221, 95-106. doi: 10.1016/S0022-1759(98)00168-9
15. Behloul, N., Wen, J., Dai, X., Dong, C., and Meng, J. (2015). Antigenic composition and immunoreactivity differences between HEV recombinant capsid proteins generated from different genotypes. Infect. Genet. Evol. 34, 211-220. doi: 10.1016/j.meegid.2015.06.026
16. Berke, T., and Matson, D. O. (2000). Reclassification of the Caliciviridae into distinct genera and exclusion of hepatitis E virus from the family on the basis of comparative phylogenetic analysis. Arch. Virol. 145, 1421-1436. doi: 10.1007/s007050070099
17. Bose, P. D., Das, B. C., Hazam, R. K., Kumar, A., Medhi, S., and Kar, P. (2014). Evidence of extrahepatic replication of hepatitis E virus in human placenta. J. Gen. Virol. 95, 1266-1271. doi: 10.1099/vir.0.063602-0
18. Burrer, R., Neuman, B. W., Ting, J. P., Stein, D. A., Moulton, H. M., Iversen, P. L., et al. (2007). Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models. J. Virol. 81, 5637-5648. doi: 10.1128/JVI.02360-06
19. Cao, D., Huang, Y. W., and Meng, X. J. (2010). The nucleotides on the stem-loop RNA structure in the junction region of the hepatitis E virus genome are critical for virus replication. J. Virol. 84, 13040-13044. doi: 10.1128/JVI.01475-10
20. Cao, D., and Meng, X. J. (2012). Molecular biology and replication of hepatitis E virus. Emerg. Microbes Infect. 1, e17. doi: 10.1038/emi.2012.7
21. CDC (2016). HEV Laboratory Testing Requests [Online]. Available: http://www.cdc.gov/hepatitis/hev/labtestingrequests.htm
22. Chandra, V., Holla, P., Ghosh, D., Chakrabarti, D., Padigaru, M., and Jameel, S. (2011). The hepatitis E virus ORF3 protein regulates the expression of liver-specific genes by modulating localization of hepatocyte nuclear factor 4. PLoS ONE 6:e22412. doi: 10.1371/journal.pone.0022412
23. Chandra, V., Kalia, M., Hajela, K., and Jameel, S. (2010). The ORF3 protein of hepatitis E virus delays degradation of activated growth factor receptors by interacting with CIN85 and blocking formation of the Cbl-CIN85 complex. J. Virol. 84, 3857-3867. doi: 10.1128/JVI.01994-09
24. Chandra, V., Kar-Roy, A., Kumari, S., Mayor, S., and Jameel, S. (2008). The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response. J. Virol. 82, 7100-7110. doi: 10.1128/JVI.00403-08
25. Chatterjee, S. N., Devhare, P. B., Pingle, S. Y., Paingankar, M. S., Arankalle, V. A., and Lole, K. S. (2016). HEV-1 harbouring HEV-4 nonstructural protein (ORF1) replicates in transfected porcine kidney cells. J. Gen. Virol. doi: 10.1099/jgv.0.000478 [Epub ahead of print].
26. Chen, L., Hu, L., Chan, T. H., Tsao, G. S., Xie, D., Huo, K. K., et al. (2009). Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival. Hepatology 50, 122-129. doi: 10.1002/hep.22933
27. Christensen, P. B., Engle, R. E., Hjort, C., Homburg, K. M., Vach, W., Georgsen, J., et al. (2008). Time trend of the prevalence of hepatitis E antibodies among farmers and blood donors: a potential zoonosis in Denmark. Clin. Infect. Dis. 47, 1026-1031. doi: 10.1086/591970
28. Cossaboom, C. M., Cordoba, L., Cao, D., Ni, Y. Y., and Meng, X. J. (2012). Complete genome sequence of hepatitis E virus from rabbits in the United States. J. Virol. 86, 13124-13125. doi: 10.1128/JVI.02414-12
29. Costanzi, C., and Pehrson, J. R. (1998). Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. Nature 393, 599-601. doi: 10.1038/31275
30. Dalton, H. R., Bendall, R., Ijaz, S., and Banks, M. (2008). Hepatitis E: an emerging infection in developed countries. Lancet Infect. Dis. 8, 698-709. doi: 10.1016/S1473-3099(08)70255-X
31. Dalton, H. R., Kamar, N., Van Eijk, J. J., Mclean, B. N., Cintas, P., Bendall, R. P., et al. (2016). Hepatitis E virus and neurological injury. Nat. Rev. Neurol. 12, 77-85. doi: 10.1038/nrneurol.2015.234
32. Debing, Y., Emerson, S. U., Wang, Y., Pan, Q., Balzarini, J., Dallmeier, K., et al. (2014a). Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon. Antimicrob. Agents Chemother. 58, 267-273. doi: 10.1128/AAC.01795-13
33. Debing, Y., Gisa, A., Dallmeier, K., Pischke, S., Bremer, B., Manns, M., et al. (2014b). A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients. Gastroenterology 147, 1008-1011 e7; quiz e15-6. doi: 10.1053/j.gastro.2014.08.040
34. Dement'eva, E. V., Semiletov Iu, A., Iashina, T. L., and Shibnev, V. A. (1997). [Analysis of the organization of immunodominant epitopes of hepatitis virus E orf2 and orf3 proteins using synthetic peptides]. Vopr. Virusol. 42, 102-105.
35. Devhare, P. B., Desai, S., and Lole, K. S. (2016). Innate immune responses in human hepatocyte-derived cell lines alter genotype 1 hepatitis E virus replication efficiencies. Sci. Rep. 6:26827. doi: 10.1038/srep26827
36. Dong, C., Zafrullah, M., Mixson-Hayden, T., Dai, X., Liang, J., Meng, J., et al. (2012). Suppression of interferon-alpha signaling by hepatitis E virus. Hepatology 55, 1324-1332. doi: 10.1002/hep.25530
37. Dosztanyi, Z., Chen, J., Dunker, A. K., Simon, I., and Tompa, P. (2006). Disorder and sequence repeats in hub proteins and their implications for network evolution. J. Proteome Res. 5, 2985-2995. doi: 10.1021/pr060171o
38. Drave, S. A., Debing, Y., Walter, S., Todt, D., Engelmann, M., Friesland, M., et al. (2016). Extra-hepatic replication and infection of hepatitis E virus in neuronal-derived cells. J. Viral. Hepat. 23:512-521. doi: 10.1111/jvh.12515
39. Drexler, J. F., Seelen, A., Corman, V. M., Fumie Tateno, A., Cottontail, V., Melim Zerbinati, R., et al. (2012). Bats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family Hepeviridae. J. Virol. 86, 9134-9147. doi: 10.1128/JVI.00800-12
40. Drobeniuc, J., Meng, J., Reuter, G., Greene-Montfort, T., Khudyakova, N., Dimitrova, Z., et al. (2010). Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin. Infect. Dis. 51, e24-e27. doi: 10.1086/654801
41. Dunker, A. K., Oldfield, C. J., Meng, J., Romero, P., Yang, J. Y., Chen, J. W., et al. (2008). The unfoldomics decade: an update on intrinsically disordered proteins. BMC Genomics 9(Suppl. 2), S1. doi: 10.1186/1471-2164-9-S2-S1
42. Egloff, M. P., Malet, H., Putics, A., Heinonen, M., Dutartre, H., Frangeul, A., et al. (2006). Structural and functional basis for ADP-ribose and poly(ADP-ribose) binding by viral macro domains. J. Virol. 80, 8493-8502. doi: 10.1128/JVI.00713-06
43. Emerson, S. U., Nguyen, H., Graff, J., Stephany, D. A., Brockington, A., and Purcell, R. H. (2004). In vitro replication of hepatitis E virus (HEV) genomes and of an HEV replicon expressing green fluorescent protein. J. Virol. 78, 4838-4846. doi: 10.1128/JVI.78.9.4838-4846.2004
44. Emerson, S. U., Nguyen, H., Torian, U., and Purcell, R. H. (2006). ORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitro. J. Virol. 80, 10457-10464. doi: 10.1128/JVI.00892-06
45. Emerson, S. U., Nguyen, H. T., Torian, U., Burke, D., Engle, R., and Purcell, R. H. (2010). Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motif. J. Virol. 84, 9059-9069. doi: 10.1128/JVI.00593-10
46. Emerson, S. U., and Purcell, R. H. (2003). Hepatitis E virus. Rev. Med. Virol. 13, 145-154. doi: 10.1002/rmv.384
47. Emerson, S. U., Zhang, M., Meng, X. J., Nguyen, H., St Claire, M., Govindarajan, S., et al. (2001). Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element. Proc. Natl. Acad. Sci. U.S.A. 98, 15270-15275. doi: 10.1073/pnas.251555098
48. Erker, J. C., Desai, S. M., Schlauder, G. G., Dawson, G. J., and Mushahwar, I. K. (1999). A hepatitis E virus variant from the United States: molecular characterization and transmission in cynomolgus macaques. J. Gen. Virol. 80 (Pt. 3), 681-690. doi: 10.1099/0022-1317-80-3-681
49. Feng, Z., Hirai-Yuki, A., Mcknight, K. L., and Lemon, S. M. (2014). Naked viruses that aren't always naked: quasi-enveloped agents of acute hepatitis. Annu. Rev. Virol. 1, 539-560. doi: 10.1146/annurev-virology-031413-085359
50. Geng, Y., Zhao, C., Huang, W., Harrison, T. J., Zhang, H., Geng, K., et al. (2016). Detection and assessment of infectivity of hepatitis E virus in urine. J. Hepatol. 64, 37-43. doi: 10.1016/j.jhep.2015.08.034
51. Geng, Y., Zhao, C., Song, A., Wang, J., Zhang, X., Harrison, T. J., et al. (2011). The serological prevalence and genetic diversity of hepatitis E virus in farmed rabbits in China. Infect. Genet. Evol. 11, 476-482. doi: 10.1016/j.meegid.2010.12.012
52. Gerolami, R., Borentain, P., Raissouni, F., Motte, A., Solas, C., and Colson, P. (2011). Treatment of severe acute hepatitis E by ribavirin. J. Clin. Virol. 52, 60-62. doi: 10.1016/j.jcv.2011.06.004
53. Gorbalenya, A. E., Koonin, E. V., and Lai, M. M. (1991). Putative papain-related thiol proteases of positive-strand RNA viruses. Identification of rubi-and aphthovirus proteases and delineation of a novel conserved domain associated with proteases of rubi-, alpha-and coronaviruses. FEBS Lett. 288, 201-205. doi: 10.1016/0014-5793(91)81034-6
54. Graff, J., Nguyen, H., Yu, C., Elkins, W. R., St Claire, M., Purcell, R. H., et al. (2005). The open reading frame 3 gene of hepatitis E virus contains a cis-reactive element and encodes a protein required for infection of macaques. J. Virol. 79, 6680-6689. doi: 10.1128/JVI.79.11.6680-6689.2005
55. Graff, J., Torian, U., Nguyen, H., and Emerson, S. U. (2006). A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus. J. Virol. 80, 5919-5926. doi: 10.1128/JVI.00046-06
56. Graff, J., Zhou, Y. H., Torian, U., Nguyen, H., St Claire, M., Yu, C., et al. (2008). Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles. J. Virol. 82, 1185-1194. doi: 10.1128/JVI.01219-07
57. Grewal, P., Kamili, S., and Motamed, D. (2014). Chronic hepatitis E in an immunocompetent patient: a case report. Hepatology 59, 347-348. doi: 10.1002/hep.26636
58. Gu, Y., Tang, X., Zhang, X., Song, C., Zheng, M., Wang, K., et al. (2015). Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody. Cell Res. 25, 604-620. doi: 10.1038/cr.2015.34
59. Guu, T. S., Liu, Z., Ye, Q., Mata, D. A., Li, K., Yin, C., et al. (2009). Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc. Natl. Acad. Sci. U.S.A. 106, 12992-12997. doi: 10.1073/pnas.0904848106
60. Haqshenas, G., Huang, F. F., Fenaux, M., Guenette, D. K., Pierson, F. W., Larsen, C. T., et al. (2002). The putative capsid protein of the newly identified avian hepatitis E virus shares antigenic epitopes with that of swine and human hepatitis E viruses and chicken big liver and spleen disease virus. J. Gen. Virol. 83, 2201-2209. doi: 10.1099/0022-1317-83-9-2201
61. Haqshenas, G., Shivaprasad, H. L., Woolcock, P. R., Read, D. H., and Meng, X. J. (2001). Genetic identification and characterization of a novel virus related to human hepatitis E virus from chickens with hepatitis-splenomegaly syndrome in the United States. J. Gen. Virol. 82, 2449-2462. doi: 10.1099/0022-1317-82-10-2449
62. He, S., Miao, J., Zheng, Z., Wu, T., Xie, M., Tang, M., et al. (2008). Putative receptor-binding sites of hepatitis E virus. J. Gen. Virol. 89, 245-249. doi: 10.1099/vir.0.83308-0
63. Helsen, N., Debing, Y., Paeshuyse, J., Dallmeier, K., Boon, R., Coll, M., et al. (2016). Stem cell-derived hepatocytes: a novel model for hepatitis E virus replication. J. Hepatol. 64, 565-573. doi: 10.1016/j.jhep.2015.11.013
64. Herremans, M., Bakker, J., Duizer, E., Vennema, H., and Koopmans, M. P. (2007). Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin. Vaccine Immunol. 14, 562-568. doi: 10.1128/CVI.00231-06
65. Holla, P., Ahmad, I., Ahmed, Z., and Jameel, S. (2015). Hepatitis E virus enters liver cells through a dynamin-2, clathrin and membrane cholesterol-dependent pathway. Traffic 16, 398-416. doi: 10.1111/tra.12260
66. Holla, R. P., Ahmad, I., Ahmad, Z., and Jameel, S. (2013). Molecular virology of hepatitis E virus. Semin. Liver Dis. 33, 3-14. doi: 10.1055/s-0033-1338110
67. Hoofnagle, J. H., Nelson, K. E., and Purcell, R. H. (2012). Hepatitis E. N. Engl. J. Med. 367, 1237-1244. doi: 10.1056/NEJMra1204512
68. Huang, F., Hua, X., Yang, S., Yuan, C., and Zhang, W. (2009). Effective inhibition of hepatitis E virus replication in A549 cells and piglets by RNA interference (RNAi) targeting RNA-dependent RNA polymerase. Antiviral Res. 83, 274-281. doi: 10.1016/j.antiviral.2009.06.008
69. Huang, F. F., Sun, Z. F., Emerson, S. U., Purcell, R. H., Shivaprasad, H. L., Pierson, F. W., et al. (2004). Determination and analysis of the complete genomic sequence of avian hepatitis E virus (avian HEV) and attempts to infect rhesus monkeys with avian HEV. J. Gen. Virol. 85, 1609-1618. doi: 10.1099/vir.0.79841-0
70. Huang, R., Nakazono, N., Ishii, K., Li, D., Kawamata, O., Kawaguchi, R., et al. (1995). Hepatitis E virus (87A strain) propagated in A549 cells. J. Med. Virol. 47, 299-302. doi: 10.1002/jmv.1890470402
71. Huang, Y. W., Opriessnig, T., Halbur, P. G., and Meng, X. J. (2007). Initiation at the third in-frame AUG codon of open reading frame 3 of the hepatitis E virus is essential for viral infectivity in vivo. J. Virol. 81, 3018-3026. doi: 10.1128/JVI.02259-06
72. Hurley, J. H. (2010). The ESCRT complexes. Crit. Rev. Biochem. Mol. Biol. 45, 463-487. doi: 10.3109/10409238.2010.502516
73. Hyams, C., Mabayoje, D. A., Copping, R., Maranao, D., Patel, M., Labbett, W., et al. (2014). Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection. J. Med. Virol. 86, 478-483. doi: 10.1002/jmv.23827
74. Ichiyama, K., Yamada, K., Tanaka, T., Nagashima, S., Jirintai, Takahashi, M., and Okamoto, H. (2009). Determination of the 5'-terminal sequence of subgenomic RNA of hepatitis E virus strains in cultured cells. Arch. Virol. 154, 1945-1951. doi: 10.1007/s00705-009-0538-y
75. Jameel, S. (1999). Molecular biology and pathogenesis of hepatitis E virus. Expert Rev. Mol. Med. 1999, 1-16. doi: 10.1017/s1462399499001271
76. Jameel, S., Zafrullah, M., Ozdener, M. H., and Panda, S. K. (1996). Expression in animal cells and characterization of the hepatitis E virus structural proteins. J. Virol. 70, 207-216.
77. Jirintai, S., Jinshan, Tanggis, Manglai, D., Mulyanto, Takahashi, M., et al. (2012). Molecular analysis of hepatitis E virus from farm rabbits in Inner Mongolia, China and its successful propagation in A549 and PLC/PRF/5 cells. Virus Res. 170, 126-137. doi: 10.1016/j.virusres.2012.09.015
78. Jirintai, S., Tanggis, Mulyanto, Suparyatmo, J. B., Takahashi, M., Kobayashi, T., et al. (2014). Rat hepatitis E virus derived from wild rats (Rattus rattus) propagates efficiently in human hepatoma cell lines. Virus Res. 185, 92-102. doi: 10.1016/j.virusres.2014.03.002
79. John, L., Thomas, S., Herchenroder, O., Putzer, B. M., and Schaefer, S. (2011). Hepatitis E virus ORF2 protein activates the pro-apoptotic gene CHOP and anti-apoptotic heat shock proteins. PLoS ONE 6:e25378. doi: 10.1371/journal.pone.0025378
80. Johne, R., Plenge-Bonig, A., Hess, M., Ulrich, R. G., Reetz, J., and Schielke, A. (2010). Detection of a novel hepatitis E-like virus in faeces of wild rats using a nested broad-spectrum RT-PCR. J. Gen. Virol. 91, 750-758. doi: 10.1099/vir.0.016584-0
81. Kabrane-Lazizi, Y., Zhang, M., Purcell, R. H., Miller, K. D., Davey, R. T., and Emerson, S. U. (2001). Acute hepatitis caused by a novel strain of hepatitis E virus most closely related to United States strains. J. Gen. Virol. 82, 1687-1693. doi: 10.1099/0022-1317-82-7-1687
82. Kadare, G., and Haenni, A. L. (1997). Virus-encoded RNA helicases. J. Virol. 71, 2583-2590.
83. Kalia, M., Chandra, V., Rahman, S. A., Sehgal, D., and Jameel, S. (2009). Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection. J. Virol. 83, 12714-12724. doi: 10.1128/JVI.00717-09
84. Kamar, N., Abravanel, F., Lhomme, S., Rostaing, L., and Izopet, J. (2014). Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment. Clin. Res. Hepatol. Gastroenterol. 39, 20-27. doi: 10.1016/j.clinre.2014.07.005
85. Kamar, N., Bendall, R., Legrand-Abravanel, F., Xia, N. S., Ijaz, S., Izopet, J., et al. (2012a). Hepatitis E. Lancet 379, 2477-2488. doi: 10.1016/S0140-6736(11)61849-7
86. Kamar, N., Bendall, R. P., Peron, J. M., Cintas, P., Prudhomme, L., Mansuy, J. M., et al. (2011). Hepatitis E virus and neurologic disorders. Emerg. Infect. Dis. 17, 173-179. doi: 10.3201/eid1702.100856
87. Kamar, N., and Izopet, J. (2014). Does chronic hepatitis E virus infection exist in immunocompetent patients? Hepatology 60:427. doi: 10.1002/hep.26927
88. Kamar, N., Mansuy, J. M., Esposito, L., Legrand-Abravanel, F., Peron, J. M., Durand, D., et al. (2005). Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient. Am. J. Kidney Dis. 45, 193-196. doi: 10.1053/j.ajkd.2004.09.006
89. Kamar, N., Rostaing, L., Abravanel, F., Garrouste, C., Lhomme, S., Esposito, L., et al. (2010). Ribavirin therapy inhibits viral replication on patients with chronic hepatitis e virus infection. Gastroenterology 139, 1612-1618. doi: 10.1053/j.gastro.2010.08.002
90. Kamar, N., Weclawiak, H., Guilbeau-Frugier, C., Legrand-Abravanel, F., Cointault, O., Ribes, D., et al. (2012b). Hepatitis E virus and the kidney in solid-organ transplant patients. Transplantation 93, 617-623. doi: 10.1097/TP.0b013e318245f14c
91. Kannan, H., Fan, S., Patel, D., Bossis, I., and Zhang, Y. J. (2009). The hepatitis E virus open reading frame 3 product interacts with microtubules and interferes with their dynamics. J. Virol. 83, 6375-6382. doi: 10.1128/JVI.02571-08
92. Kapur, N., Thakral, D., Durgapal, H., and Panda, S. K. (2012). Hepatitis E virus enters liver cells through receptor-dependent clathrin-mediated endocytosis. J. Viral. Hepat. 19, 436-448. doi: 10.1111/j.1365-2893.2011.01559.x
93. Karpe, Y. A., and Lole, K. S. (2010a). NTPase and 5' to 3' RNA duplex-unwinding activities of the hepatitis E virus helicase domain. J. Virol. 84, 3595-3602. doi: 10.1128/JVI.02130-09
94. Karpe, Y. A., and Lole, K. S. (2010b). RNA 5'-triphosphatase activity of the hepatitis E virus helicase domain. J. Virol. 84, 9637-9641. doi: 10.1128/JVI.00492-10
95. Karpe, Y. A., and Lole, K. S. (2011). Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease. J. Gen. Virol. 92, 2088-2092. doi: 10.1099/vir.0.033738-0
96. Kar-Roy, A., Korkaya, H., Oberoi, R., Lal, S. K., and Jameel, S. (2004). The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase. J. Biol. Chem. 279, 28345-28357. doi: 10.1074/jbc. M400457200
97. Kenney, S. P., and Meng, X. J. (2015a). Identification and fine mapping of nuclear and nucleolar localization signals within the human ribosomal protein S17. PLoS ONE 10, e0124396. doi: 10.1371/journal.pone.0124396
98. Kenney, S. P., and Meng, X. J. (2015b). The lysine residues within the human ribosomal protein S17 sequence naturally inserted into the viral nonstructural protein of a unique strain of hepatitis E virus are important for enhanced virus replication. J. Virol. 89, 3793-3803. doi: 10.1128/JVI.03582-14
99. Kenney, S. P., Pudupakam, R. S., Huang, Y. W., Pierson, F. W., Leroith, T., and Meng, X. J. (2012). The PSAP motif within the ORF3 protein of an avian strain of the hepatitis E virus is not critical for viral infectivity in vivo but plays a role in virus release. J. Virol. 86, 5637-5646. doi: 10.1128/JVI.06711-11
100. Kenney, S. P., Wentworth, J. L., Heffron, C. L., and Meng, X. J. (2015). Replacement of the hepatitis E virus ORF3 protein PxxP motif with heterologous late domain motifs affects virus release via interaction with TSG101. Virology 486, 198-208. doi: 10.1016/j.virol.2015.09.012
101. Koizumi, Y., Isoda, N., Sato, Y., Iwaki, T., Ono, K., Ido, K., et al. (2004). Infection of a Japanese patient by genotype 4 hepatitis e virus while traveling in Vietnam. J. Clin. Microbiol. 42, 3883-3885. doi: 10.1128/JCM.42.8.3883-3885.2004
102. Koonin, E. V. (1991). The phylogeny of RNA-dependent RNA polymerases of positive-strand RNA viruses. J. Gen. Virol. 72 (Pt. 9), 2197-2206. doi: 10.1099/0022-1317-72-9-2197
103. Koonin, E. V., and Dolja, V. V. (1993). Evolution and taxonomy of positive-strand RNA viruses: implications of comparative analysis of amino acid sequences. Crit. Rev. Biochem. Mol. Biol. 28, 375-430. doi: 10.3109/10409239309078440
104. Koonin, E. V., Gorbalenya, A. E., Purdy, M. A., Rozanov, M. N., Reyes, G. R., and Bradley, D. W. (1992). Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Proc. Natl. Acad. Sci. U.S.A. 89, 8259-8263. doi: 10.1073/pnas.89.17.8259
105. Korkaya, H., Jameel, S., Gupta, D., Tyagi, S., Kumar, R., Zafrullah, M., et al. (2001). The ORF3 protein of hepatitis E virus binds to Src homology 3 domains and activates MAPK. J. Biol. Chem. 276, 42389-42400. doi: 10.1074/jbc. M101546200
106. Krain, L. J., Atwell, J. E., Nelson, K. E., and Labrique, A. B. (2014). Fetal and neonatal health consequences of vertically transmitted hepatitis E virus infection. Am. J. Trop. Med. Hyg. 90, 365-370. doi: 10.4269/ajtmh.13-0265
107. Krog, J. S., Breum, S. O., Jensen, T. H., and Larsen, L. E. (2013). Hepatitis E virus variant in farmed mink, Denmark. Emerg. Infect. Dis. 19, 2028-2030. doi: 10.3201/eid1912.130614
108. Kumar, A., Devi, S. G., Kar, P., Agarwal, S., Husain, S. A., Gupta, R. K., et al. (2014). Association of cytokines in hepatitis E with pregnancy outcome. Cytokine 65, 95-104. doi: 10.1016/j.cyto.2013.09.022
109. Kumar, A., Panda, S. K., Durgapal, H., Acharya, S. K., Rehman, S., and Kar, U. K. (2010). Inhibition of Hepatitis E virus replication using short hairpin RNA (shRNA). Antiviral Res. 85, 541-550. doi: 10.1016/j.antiviral.2010.01.005
110. Kwo, P. Y., Schlauder, G. G., Carpenter, H. A., Murphy, P. J., Rosenblatt, J. E., Dawson, G. J., et al. (1997). Acute hepatitis E by a new isolate acquired in the United States. Mayo Clin. Proc. 72, 1133-1136. doi: 10.4065/72.12.1133
111. Lapa, D., Capobianchi, M. R., and Garbuglia, A. R. (2015). Epidemiology of Hepatitis E virus in European Countries. Int. J. Mol. Sci. 16, 25711-25743. doi: 10.3390/ijms161025711
112. Lhomme, S., Garrouste, C., Kamar, N., Saune, K., Abravanel, F., Mansuy, J. M., et al. (2014). Influence of polyproline region and macro domain genetic heterogeneity on HEV persistence in immunocompromised patients. J. Infect. Dis. 209, 300-303. doi: 10.1093/infdis/jit438
113. Lhomme, S., Kamar, N., Nicot, F., Ducos, J., Bismuth, M., Garrigue, V., et al. (2015). Mutation in the Hepatitis E virus polymerase and outcome of ribavirin therapy. Antimicrob. Agents Chemother. 60, 1608-1614. doi: 10.1128/AAC.02496-15
114. Li, C., Debing, Y., Jankevicius, G., Neyts, J., Ahel, I., Coutard, B., et al. (2016). Viral macro domains reverse protein ADP-ribosylation. J. Virol. doi: 10.1128/JVI.00705-16 [Epub ahead of print].
115. Li, H., Zheng, Z., Zhou, P., Zhang, B., Shi, Z., Hu, Q., et al. (2010). The cysteine protease domain of porcine reproductive and respiratory syndrome virus non-structural protein 2 antagonizes interferon regulatory factor 3 activation. J. Gen. Virol. 91, 2947-2958. doi: 10.1099/vir.0.025205-0
116. Li, S. W., Zhang, J., He, Z. Q., Gu, Y., Liu, R. S., Lin, J., et al. (2005a). Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. J. Biol. Chem. 280, 3400-3406. doi: 10.1074/jbc. M410361200
117. Li, S. W., Zhang, J., Li, Y. M., Ou, S. H., Huang, G. Y., He, Z. Q., et al. (2005b). A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 23, 2893-2901. doi: 10.1016/j.vaccine.2004.11.064
118. Li, T. C., Chijiwa, K., Sera, N., Ishibashi, T., Etoh, Y., Shinohara, Y., et al. (2005c). Hepatitis E virus transmission from wild boar meat. Emerg. Infect. Dis. 11, 1958-1960. doi: 10.3201/eid1112.051041
119. Li, T. C., Takeda, N., Miyamura, T., Matsuura, Y., Wang, J. C., Engvall, H., et al. (2005d). Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus. J. Virol. 79, 12999-13006. doi: 10.1128/JVI.79.20.12999-13006.2005
120. Li, T. C., Yamakawa, Y., Suzuki, K., Tatsumi, M., Razak, M. A., Uchida, T., et al. (1997). Expression and self-assembly of empty virus-like particles of hepatitis E virus. J. Virol. 71, 7207-7213.
121. Liang, Y., Yao, J., and Gillam, S. (2000). Rubella virus nonstructural protein protease domains involved in trans-and cis-cleavage activities. J. Virol. 74, 5412-5423. doi: 10.1128/JVI.74.12.5412-5423.2000
122. Lin, J., Norder, H., Uhlhorn, H., Belak, S., and Widen, F. (2014). Novel hepatitis E like virus found in Swedish moose. J. Gen. Virol. 95, 557-570. doi: 10.1099/vir.0.059238-0
123. Liu, H., Fu, Y., Jiang, D., Li, G., Xie, J., Peng, Y., et al. (2009). A novel mycovirus that is related to the human pathogen hepatitis E virus and rubi-like viruses. J. Virol. 83, 1981-1991. doi: 10.1128/JVI.01897-08
124. Liu, P., Du, R., Wang, L., Han, J., Liu, L., Zhang, Y., et al. (2014). Management of hepatitis E virus (HEV) zoonotic transmission: protection of rabbits against HEV challenge following immunization with HEV 239 vaccine. PLoS ONE 9:e87600. doi: 10.1371/journal.pone.0087600
125. Liu, X., Wang, Q., Chen, W., and Wang, C. (2013). Dynamic regulation of innate immunity by ubiquitin and ubiquitin-like proteins. Cytokine Growth Factor Rev. 24, 559-570. doi: 10.1016/j.cytogfr.2013.07.002
126. Lorenzo, F. R., Tsatsralt-Od, B., Ganbat, S., Takahashi, M., and Okamoto, H. (2007). Analysis of the full-length genome of hepatitis E virus isolates obtained from farm pigs in Mongolia. J. Med. Virol. 79, 1128-1137. doi: 10.1002/jmv.20905
127. Lu, L., Li, C., and Hagedorn, C. H. (2006). Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev. Med. Virol. 16, 5-36. doi: 10.1002/rmv.482
128. Magden, J., Takeda, N., Li, T., Auvinen, P., Ahola, T., Miyamura, T., et al. (2001). Virus-specific mRNA capping enzyme encoded by hepatitis E virus. J. Virol. 75, 6249-6255. doi: 10.1128/JVI.75.14.6249-6255.2001
129. Majumdar, M., Ratho, R. K., Chawla, Y., and Singh, M. P. (2015). Role of TLR gene expression and cytokine profiling in the immunopathogenesis of viral hepatitis E. J. Clin. Virol. 73, 8-13. doi: 10.1016/j.jcv.2015.09.011
130. Mallet, V., Nicand, E., Sultanik, P., Chakvetadze, C., Tesse, S., Thervet, E., et al. (2010). Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann. Intern. Med. 153, 85-89. doi: 10.7326/0003-4819-153-2-201007200-00257
131. Mao, A. P., Li, S., Zhong, B., Li, Y., Yan, J., Li, Q., et al. (2010). Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-beta (IFN-beta) and cellular antiviral response. J. Biol. Chem. 285, 9470-9476. doi: 10.1074/jbc. M109.071043
132. Marr, L. D., Wang, C. Y., and Frey, T. K. (1994). Expression of the rubella virus nonstructural protein ORF and demonstration of proteolytic processing. Virology 198, 586-592. doi: 10.1006/viro.1994.1070
133. Martzen, M. R., Mccraith, S. M., Spinelli, S. L., Torres, F. M., Fields, S., Grayhack, E. J., et al. (1999). A biochemical genomics approach for identifying genes by the activity of their products. Science 286, 1153-1155. doi: 10.1126/science.286.5442.1153
134. Mast, E. E., Alter, M. J., Holland, P. V., and Purcell, R. H. (1998). Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatitis E virus antibody serum panel evaluation group. Hepatology 27, 857-861. doi: 10.1002/hep.510270331
135. McAtee, C. P., Zhang, Y., Yarbough, P. O., Bird, T., and Fuerst, T. R. (1996). Purification of a soluble hepatitis E open reading frame 2-derived protein with unique antigenic properties. Protein Expr. Purif. 8, 262-270. doi: 10.1006/prep.1996.0099
136. Mendell, J. R., Rodino-Klapac, L. R., Sahenk, Z., Roush, K., Bird, L., Lowes, L. P., et al. (2013). Eteplirsen for the treatment of Duchenne muscular dystrophy. Ann. Neurol. 74, 637-647. doi: 10.1002/ana.23982
137. Meng, J., Dai, X., Chang, J. C., Lopareva, E., Pillot, J., Fields, H. A., et al. (2001). Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology 288, 203-211. doi: 10.1006/viro.2001.1093
138. Meng, X. J. (2010). Recent advances in Hepatitis E virus. J. Viral. Hepat. 17, 153-161. doi: 10.1111/j.1365-2893.2009.01257.x
139. Meng, X. J. (2013). Zoonotic and foodborne transmission of hepatitis E virus. Semin. Liver Dis. 33, 41-49. doi: 10.1055/s-0033-1338113
140. Meng, X. J., Purcell, R. H., Halbur, P. G., Lehman, J. R., Webb, D. M., Tsareva, T. S., et al. (1997). A novel virus in swine is closely related to the human hepatitis E virus. Proc. Natl. Acad. Sci. U.S.A. 94, 9860-9865. doi: 10.1073/pnas.94.18.9860
141. Mhaindarkar, V., Sharma, K., and Lole, K. S. (2014). Mutagenesis of hepatitis E virus helicase motifs: effects on enzyme activity. Virus Res. 179, 26-33. doi: 10.1016/j.virusres.2013.11.022
142. Midgley, S., Vestergaard, H. T., Dalgaard, C., Enggaard, L., and Fischer, T. K. (2014). Hepatitis E virus genotype 4, Denmark, 2012. Emerg. Infect. Dis. 20, 156-157. doi: 10.3201/eid2001.130600
143. Mizuo, H., Suzuki, K., Takikawa, Y., Sugai, Y., Tokita, H., Akahane, Y., et al. (2002). Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan. J. Clin. Microbiol. 40, 3209-3218. doi: 10.1128/JCM.40.9.3209-3218.2002
144. Moin, S. M., Chandra, V., Arya, R., and Jameel, S. (2009). The hepatitis E virus ORF3 protein stabilizes HIF-1alpha and enhances HIF-1-mediated transcriptional activity through p300/CBP. Cell Microbiol. 11, 1409-1421. doi: 10.1111/j.1462-5822.2009.01340.x
145. Moin, S. M., Panteva, M., and Jameel, S. (2007). The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death. J. Biol. Chem. 282, 21124-21133. doi: 10.1074/jbc. M701696200
146. Mori, Y., and Matsuura, Y. (2011). Structure of hepatitis E viral particle. Virus Res. 161, 59-64. doi: 10.1016/j.virusres.2011.03.015
147. Moulton, H. M. (2013). In vivo delivery of morpholino oligos by cell-penetrating peptides. Curr. Pharm. Des. 19, 2963-2969. doi: 10.2174/1381612811319160010
148. Nagashima, S., Takahashi, M., Jirintai, S., Tanggis, Kobayashi, T., Nishizawa, T., and Okamoto, H. (2014). The membrane on the surface of hepatitis E virus particles is derived from the intracellular membrane and contains trans-Golgi network protein 2. Arch. Virol. 159, 979-991. doi: 10.1007/s00705-013-1912-3
149. Nagashima, S., Takahashi, M., Jirintai, S., Tanaka, T., Nishizawa, T., Yasuda, J., et al. (2011a). Tumour susceptibility gene 101 and the vacuolar protein sorting pathway are required for the release of hepatitis E virions. J. Gen. Virol. 92(Pt. 12), 2838-2848. doi: 10.1099/vir.0.035378-0
150. Nagashima, S., Takahashi, M., Jirintai, Tanaka, T., Yamada, K., Nishizawa, T., et al. (2011b). A PSAP motif in the ORF3 protein of hepatitis E virus is necessary for virion release from infected cells. J. Gen. Virol. 92, 269-278. doi: 10.1099/vir.0.025791-0
151. Nair, V. P., Anang, S., Subramani, C., Madhvi, A., Bakshi, K., Srivastava, A., et al. (2016). Endoplasmic reticulum stress induced synthesis of a novel viral factor mediates efficient replication of genotype-1 hepatitis E virus. PLoS Pathog. 12:e1005521. doi: 10.1371/journal.ppat.1005521
152. Nan, Y. (2014). Interferense of Host Innate Immune Response by Hepatitis E Virus. Ph. D. thesis, University of Maryland, College Park, College Park, MD.
153. Nan, Y., Ma, Z., Kannan, H., Stein, D. A., Iversen, P. I., Meng, X. J., et al. (2015). Inhibition of hepatitis E virus replication by peptide-conjugated morpholino oligomers. Antiviral Res. 120, 134-139. doi: 10.1016/j.antiviral.2015.06.006
154. Nan, Y., Ma, Z., Wang, R., Yu, Y., Kannan, H., Fredericksen, B., et al. (2014a). Enhancement of interferon induction by ORF3 product of hepatitis E virus. J. Virol. 88, 8696-8705. doi: 10.1128/JVI.01228-14
155. Nan, Y., Yu, Y., Ma, Z., Khattar, S. K., Fredericksen, B., and Zhang, Y. J. (2014b). Hepatitis E virus inhibits type I interferon induction by ORF1 products. J. Virol. 88, 11924-11932. doi: 10.1128/JVI.01935-14
156. Neuvonen, M., and Ahola, T. (2009). Differential activities of cellular and viral macro domain proteins in binding of ADP-ribose metabolites. J. Mol. Biol. 385, 212-225. doi: 10.1016/j.jmb.2008.10.045
157. Ojha, N. K., and Lole, K. S. (2016). Hepatitis E virus ORF1 encoded macro domain protein interacts with light chain subunit of human ferritin and inhibits its secretion. Mol. Cell. Biochem. 417, 75-85. doi: 10.1007/s11010-016-2715-0
158. Okamoto, H. (2007). Genetic variability and evolution of hepatitis E virus. Virus Res. 127, 216-228. doi: 10.1016/j.virusres.2007.02.002
159. Okamoto, H. (2011). Efficient cell culture systems for hepatitis E virus strains in feces and circulating blood. Rev. Med. Virol. 21, 18-31. doi: 10.1002/rmv.678
160. Okamoto, H. (2013). Culture systems for hepatitis E virus. J. Gastroenterol. 48, 147-158. doi: 10.1007/s00535-012-0682-0
161. O'Reilly, E. K., and Kao, C. C. (1998). Analysis of RNA-dependent RNA polymerase structure and function as guided by known polymerase structures and computer predictions of secondary structure. Virology 252, 287-303. doi: 10.1006/viro.1998.9463
162. Osterman, A., Stellberger, T., Gebhardt, A., Kurz, M., Friedel, C. C., Uetz, P., et al. (2015). The hepatitis E virus intraviral interactome. Sci. Rep. 5, 13872. doi: 10.1038/srep13872
163. Paessler, S., Rijnbrand, R., Stein, D. A., Ni, H., Yun, N. E., Dziuba, N., et al. (2008). Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers. Virology 376, 357-370. doi: 10.1016/j.virol.2008.03.032
164. Paliwal, D., Panda, S. K., Kapur, N., Varma, S. P., and Durgapal, H. (2014). Hepatitis E virus (HEV) protease: a chymotrypsin-like enzyme that processes both non-structural (pORF1) and capsid (pORF2) protein. J. Gen. Virol. 95(Pt. 8), 1689-700. doi: 10.1099/vir.0.066142-0
165. Panda, S. K., Ansari, I. H., Durgapal, H., Agrawal, S., and Jameel, S. (2000). The in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious. J. Virol. 74, 2430-2437. doi: 10.1128/JVI.74.5.2430-2437.2000
166. Parvez, M. K. (2013). Molecular characterization of hepatitis E virus ORF1 gene supports a papain-like cysteine protease (PCP)-domain activity. Virus Res. 178, 553-556. doi: 10.1016/j.virusres.2013.07.020
167. Parvez, M. K. (2015a). The hepatitis E virus ORF1 'X-domain' residues form a putative macrodomain protein/Appr-1-pase catalytic-site, critical for viral RNA replication. Gene 566, 47-53. doi: 10.1016/j.gene.2015.04.026
168. Parvez, M. K. (2015b). The intergenic-junction variant (genotype 2 isolate) of hepatitis E virus restores the CREX 'stem-loop' structural integrity, essential for viral life cycle. Gene 559, 149-154. doi: 10.1016/j.gene.2015.01.033
169. Parvez, M. K., and Al-Dosari, M. S. (2015). Evidence of MAPK-JNK1/2 activation by hepatitis E virus ORF3 protein in cultured hepatoma cells. Cytotechnology 67, 545-550. doi: 10.1007/s10616-014-9785-1
170. Pas, S. D., De Man, R. A., Mulders, C., Balk, A. H., Van Hal, P. T., Weimar, W., et al. (2012). Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg. Infect. Dis. 18, 869-872. doi: 10.3201/eid1805.111712
171. Pasdeloup, D., Mcelwee, M., Beilstein, F., Labetoulle, M., and Rixon, F. J. (2013). Herpesvirus tegument protein pUL37 interacts with dystonin/BPAG1 to promote capsid transport on microtubules during egress. J. Virol. 87, 2857-2867. doi: 10.1128/JVI.02676-12
172. Pavio, N., Meng, X. J., and Doceul, V. (2015). Zoonotic origin of hepatitis E. Curr. Opin. Virol. 10, 34-41. doi: 10.1016/j.coviro.2014.12.006
173. Pehrson, J. R., and Fried, V. A. (1992). MacroH2A, a core histone containing a large nonhistone region. Science 257, 1398-1400. doi: 10.1126/science.1529340
174. Pehrson, J. R., and Fuji, R. N. (1998). Evolutionary conservation of histone macroH2A subtypes and domains. Nucleic Acids Res. 26, 2837-2842. doi: 10.1093/nar/26.12.2837
175. Perche, P. Y., Vourc'h, C., Konecny, L., Souchier, C., Robert-Nicoud, M., Dimitrov, S., et al. (2000). Higher concentrations of histone macroH2A in the Barr body are correlated with higher nucleosome density. Curr. Biol. 10, 1531-1534. doi: 10.1016/S0960-9822(00)00832-0
176. Perttila, J., Spuul, P., and Ahola, T. (2013). Early secretory pathway localization and lack of processing for hepatitis E virus replication protein pORF1. J. Gen. Virol. 94, 807-816. doi: 10.1099/vir.0.049577-0
177. Pudupakam, R. S., Huang, Y. W., Opriessnig, T., Halbur, P. G., Pierson, F. W., and Meng, X. J. (2009). Deletions of the hypervariable region (HVR) in open reading frame 1 of hepatitis E virus do not abolish virus infectivity: evidence for attenuation of HVR deletion mutants in vivo. J. Virol. 83, 384-395. doi: 10.1128/JVI.01854-08
178. Pudupakam, R. S., Kenney, S. P., Cordoba, L., Huang, Y. W., Dryman, B. A., Leroith, T., et al. (2011). Mutational analysis of the hypervariable region of hepatitis e virus reveals its involvement in the efficiency of viral RNA replication. J. Virol. 85, 10031-10040. doi: 10.1128/JVI.00763-11
179. Purcell, R. H., and Emerson, S. U. (2008). Hepatitis E: an emerging awareness of an old disease. J. Hepatol. 48, 494-503. doi: 10.1016/j.jhep.2007.12.008
180. Purdy, M. A. (2012). Evolution of the hepatitis E virus polyproline region: order from disorder. J. Virol. 86, 10186-10193. doi: 10.1128/JVI.01374-12
181. Purdy, M. A., and Khudyakov, Y. E. (2011). The molecular epidemiology of hepatitis E virus infection. Virus Res. 161, 31-39. doi: 10.1016/j.virusres.2011.04.030
182. Purdy, M. A., Lara, J., and Khudyakov, Y. E. (2012). The hepatitis E virus polyproline region is involved in viral adaptation. PLoS ONE 7, e35974. doi: 10.1371/journal.pone.0035974
183. Putics, A., Filipowicz, W., Hall, J., Gorbalenya, A. E., and Ziebuhr, J. (2005). ADP-ribose-1"-monophosphatase: a conserved coronavirus enzyme that is dispensable for viral replication in tissue culture. J. Virol. 79, 12721-12731. doi: 10.1128/JVI.79.20.12721-12731.2005
184. Putics, A., Gorbalenya, A. E., and Ziebuhr, J. (2006). Identification of protease and ADP-ribose 1"-monophosphatase activities associated with transmissible gastroenteritis virus non-structural protein 3. J. Gen. Virol. 87, 651-656. doi: 10.1099/vir.0.81596-0
185. Qi, Y., Zhang, F., Zhang, L., Harrison, T. J., Huang, W., Zhao, C., et al. (2015). Hepatitis E virus produced from cell culture has a lipid envelope. PLoS ONE 10:e0132503. doi: 10.1371/journal.pone.0132503
186. Raeder, R., Woischnik, M., Podbielski, A., and Boyle, M. D. (1998). A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res. Microbiol. 149, 539-548. doi: 10.1016/S0923-2508(99)80001-1
187. Raj, V. S., Smits, S. L., Pas, S. D., Provacia, L. B., Moorman-Roest, H., Osterhaus, A. D., et al. (2012). Novel hepatitis E virus in ferrets, the Netherlands. Emerg. Infect. Dis. 18, 1369-1370. doi: 10.3201/eid1808.111659
188. Ratra, R., Kar-Roy, A., and Lal, S. K. (2008). The ORF3 protein of hepatitis E virus interacts with hemopexin by means of its 26 amino acid N-terminal hydrophobic domain II. Biochemistry 47, 1957-1969. doi: 10.1021/bi7016552
189. Ratra, R., Kar-Roy, A., and Lal, S. K. (2009). ORF3 protein of hepatitis E virus interacts with the Bbeta chain of fibrinogen resulting in decreased fibrinogen secretion from HuH-7 cells. J. Gen. Virol. 90, 1359-1370. doi: 10.1099/vir.0.009274-0
190. Rehman, S., Kapur, N., Durgapal, H., and Panda, S. K. (2008). Subcellular localization of hepatitis E virus (HEV) replicase. Virology 370, 77-92. doi: 10.1016/j.virol.2007.07.036
191. Reyes, G. R., Huang, C. C., Tam, A. W., and Purdy, M. A. (1993). Molecular organization and replication of hepatitis E virus (HEV). Arch. Virol. Suppl. 7, 15-25. doi: 10.1007/978-3-7091-9300-6_2
192. Reyes, G. R., Purdy, M. A., Kim, J. P., Luk, K. C., Young, L. M., Fry, K. E., et al. (1990). Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 247, 1335-1339. doi: 10.1126/science.2107574
193. Robinson, R. A., Burgess, W. H., Emerson, S. U., Leibowitz, R. S., Sosnovtseva, S. A., Tsarev, S., et al. (1998). Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expr. Purif. 12, 75-84. doi: 10.1006/prep.1997.0817
194. Rogee, S., Talbot, N., Caperna, T., Bouquet, J., Barnaud, E., and Pavio, N. (2013). New models of hepatitis E virus replication in human and porcine hepatocyte cell lines. J. Gen. Virol. 94, 549-558. doi: 10.1099/vir.0.049858-0
195. Ropp, S. L., Tam, A. W., Beames, B., Purdy, M., and Frey, T. K. (2000). Expression of the hepatitis E virus ORF1. Arch. Virol. 145, 1321-1337. doi: 10.1007/s007050070093
196. Rozanov, M. N., Koonin, E. V., and Gorbalenya, A. E. (1992). Conservation of the putative methyltransferase domain: a hallmark of the 'Sindbis-like' supergroup of positive-strand RNA viruses. J. Gen. Virol. 73 (Pt 8), 2129-2134. doi: 10.1099/0022-1317-73-8-2129
197. Sadler, G. J., Mells, G. F., Shah, N. H., Chesner, I. M., and Walt, R. P. (2006). UK acquired hepatitis E-An emerging problem? J. Med. Virol. 78, 473-475. doi: 10.1002/jmv.20564
198. Saikatendu, K. S., Joseph, J. S., Subramanian, V., Clayton, T., Griffith, M., Moy, K., et al. (2005). Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1"-phosphate dephosphorylation by a conserved domain of nsP3. Structure 13, 1665-1675. doi: 10.1016/j.str.2005.07.022
199. Sanford, B. J., Opriessnig, T., Kenney, S. P., Dryman, B. A., Cordoba, L., and Meng, X. J. (2012). Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs. Vaccine 30, 6249-6255. doi: 10.1016/j.vaccine.2012.08.013
200. Sayed, I. M., Vercouter, A. S., Abdelwahab, S. F., Vercauteren, K., and Meuleman, P. (2015). Is hepatitis E virus an emerging problem in industrialized countries? Hepatology 62, 1883-1892. doi: 10.1002/hep.27990
201. Schlauder, G. G., Desai, S. M., Zanetti, A. R., Tassopoulos, N. C., and Mushahwar, I. K. (1999). Novel hepatitis E virus (HEV) isolates from Europe: evidence for additional genotypes of HEV. J. Med. Virol. 57, 243-251. doi: 10.1002/(SICI)1096-9071(199903)57:3<243::AID-JMV6>3.0.CO;2-R
202. Schofield, D. J., Glamann, J., Emerson, S. U., and Purcell, R. H. (2000). Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. J. Virol. 74, 5548-5555. doi: 10.1128/JVI.74.12.5548-5555.2000
203. Sehgal, D., Thomas, S., Chakraborty, M., and Jameel, S. (2006). Expression and processing of the Hepatitis E virus ORF1 nonstructural polyprotein. Virol. J. 3, 38. doi: 10.1186/1743-422X-3-38
204. Semiletov, Y. A., Dementeva, E. V., Yashina, T. L., Favorov, M. O., and Shibnev, V. A. (1995). Synthesis and antigenic activity of peptides from the Orf3 protein-sequence of hepatitis-E virus. Bioorg. Khim. 21, 156-157.
205. Shrestha, M. P., Scott, R. M., Joshi, D. M., Mammen, M. P. Jr., Thapa, G. B., Thapa, N., et al. (2007). Safety and efficacy of a recombinant hepatitis E vaccine. N. Engl. J. Med. 356, 895-903. doi: 10.1056/NEJMoa061847
206. Shukla, P., Nguyen, H. T., Torian, U., Engle, R. E., Faulk, K., Dalton, H. R., et al. (2011). Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc. Natl. Acad. Sci. U.S.A. 108, 2438-2443. doi: 10.1073/pnas.1018878108
207. Singleton, M. R., Dillingham, M. S., and Wigley, D. B. (2007). Structure and mechanism of helicases and nucleic acid translocases. Annu. Rev. Biochem. 76, 23-50. doi: 10.1146/annurev.biochem.76.052305.115300
208. Smith, D. B., Purdy, M. A., and Simmonds, P. (2013). Genetic variability and the classification of hepatitis E virus. J. Virol. 87, 4161-4169. doi: 10.1128/JVI.02762-12
209. Smith, D. B., Simmonds, P., Izopet, J., Oliveira-Filho, E. F., Ulrich, R. G., Johne, R., et al. (2016). Proposed reference sequences for hepatitis E virus subtypes. J. Gen. Virol. 97, 537-542. doi: 10.1099/jgv.0.000393
210. Smith, D. B., Simmonds, P., Jameel, S., Emerson, S. U., Harrison, T. J., Meng, X. J., et al. (2014). Consensus proposals for classification of the family Hepeviridae. J. Gen. Virol. 95, 2223-2232. doi: 10.1099/vir.0.068429-0
211. Sue, P. K., Pisanic, N., Heaney, C. D., Forman, M., Valsamakis, A., Jackson, A. M., et al. (2016). Hepatitis E virus infection among solid organ transplant recipients at a North American transplant center. Open Forum Infect. Dis. 3:ofw006. doi: 10.1093/ofid/ofw006
212. Summerton, J. (1999). Morpholino antisense oligomers: the case for an RNase H-independent structural type. Biochim. Biophys. Acta 1489, 141-158. doi: 10.1016/S0167-4781(99)00150-5
213. Sun, Z., Chen, Z., Lawson, S. R., and Fang, Y. (2010). The cysteine protease domain of porcine reproductive and respiratory syndrome virus nonstructural protein 2 possesses deubiquitinating and interferon antagonism functions. J. Virol. 84, 7832-7846. doi: 10.1128/JVI.00217-10
214. Suppiah, S., Zhou, Y., and Frey, T. K. (2011). Lack of processing of the expressed ORF1 gene product of hepatitis E virus. Virol. J. 8, 245. doi: 10.1186/1743-422X-8-245
215. Surjit, M., Jameel, S., and Lal, S. K. (2004). The ORF2 protein of hepatitis E virus binds the 5' region of viral RNA. J. Virol. 78, 320-328. doi: 10.1128/JVI.78.1.320-328.2004
216. Surjit, M., Varshney, B., and Lal, S. K. (2012). The ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-kappaB activity by blocking ubiquitination mediated proteasomal degradation of IkappaBalpha in human hepatoma cells. BMC Biochem. 13:7. doi: 10.1186/1471-2091-13-7
217. Takahashi, H., Tanaka, T., Jirintai, S., Nagashima, S., Takahashi, M., Nishizawa, T., et al. (2012). A549 and PLC/PRF/5 cells can support the efficient propagation of swine and wild boar hepatitis E virus (HEV) strains: demonstration of HEV infectivity of porcine liver sold as food. Arch. Virol. 157, 235-246. doi: 10.1007/s00705-011-1153-2
218. Takahashi, K., Kitajima, N., Abe, N., and Mishiro, S. (2004). Complete or near-complete nucleotide sequences of hepatitis E virus genome recovered from a wild boar, a deer, and four patients who ate the deer. Virology 330, 501-505. doi: 10.1016/j.virol.2004.10.006
219. Takahashi, M., Nishizawa, T., Sato, H., Sato, Y., Jirintai, Nagashima, S., et al. (2011). Analysis of the full-length genome of a hepatitis E virus isolate obtained from a wild boar in Japan that is classifiable into a novel genotype. J. Gen. Virol. 92, 902-908. doi: 10.1099/vir.0.029470-0
220. Takahashi, M., Tanaka, T., Takahashi, H., Hoshino, Y., Nagashima, S., Jirintai, et al. (2010). Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation. J. Clin. Microbiol. 48, 1112-1125. doi: 10.1128/JCM.02002-09
221. Takahashi, M., Yamada, K., Hoshino, Y., Takahashi, H., Ichiyama, K., Tanaka, T., et al. (2008). Monoclonal antibodies raised against the ORF3 protein of hepatitis E virus (HEV) can capture HEV particles in culture supernatant and serum but not those in feces. Arch. Virol. 153, 1703-1713. doi: 10.1007/s00705-008-0179-6
222. Tam, A. W., Smith, M. M., Guerra, M. E., Huang, C. C., Bradley, D. W., Fry, K. E., et al. (1991). Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185, 120-131. doi: 10.1016/0042-6822(91)90760-9
223. Tam, A.W., White, R., Reed, E., Short, M., Zhang, Y., Fuerst, T.R., et al. (1996). In vitro propagation and production of hepatitis E virus from in vivo-infected primary macaque hepatocytes. Virology 215, 1-9. doi: 10.1006/viro.1996.0001
224. Tanaka, T., Takahashi, M., Kusano, E., and Okamoto, H. (2007). Development and evaluation of an efficient cell-culture system for hepatitis E virus. J. Gen. Virol. 88, 903-911. doi: 10.1099/vir.0.82535-0
225. Tanaka, T., Takahashi, M., Takahashi, H., Ichiyama, K., Hoshino, Y., Nagashima, S., et al. (2009). Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patient. J. Clin. Microbiol. 47, 1906-1910. doi: 10.1128/JCM.00629-09
226. Tang, Z. M., Tang, M., Zhao, M., Wen, G. P., Yang, F., Cai, W., et al. (2015). A novel linear neutralizing epitope of hepatitis E virus. Vaccine 33, 3504-3511. doi: 10.1016/j.vaccine.2015.05.065
227. Tei, S., Kitajima, N., Takahashi, K., and Mishiro, S. (2003). Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 362, 371-373. doi: 10.1016/S0140-6736(03)14025-1
228. Todt, D., Gisa, A., Radonic, A., Nitsche, A., Behrendt, P., Suneetha, P.V., et al. (2016). In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome. Gut doi: 10.1136/gutjnl-2015-311000. [Epub ahead ofprint]
229. Tsai, C. J., Ma, B., Sham, Y. Y., Kumar, S., and Nussinov, R. (2001). Structured disorder and conformational selection. Proteins 44, 418-427. doi: 10.1002/prot.1107
230. Tsarev, S. A., Emerson, S. U., Reyes, G. R., Tsareva, T. S., Legters, L. J., Malik, I. A., et al. (1992). Characterization of a prototype strain of hepatitis E virus. Proc. Natl. Acad. Sci. U.S.A. 89, 559-563. doi: 10.1073/pnas.89.2.559
231. Tsarev, S. A., Tsareva, T. S., Emerson, S. U., Kapikian, A. Z., Ticehurst, J., London, W., et al. (1993). ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J. Infect. Dis. 168, 369-378. doi: 10.1093/infdis/168.2.369
232. Tyagi, S., Jameel, S., and Lal, S. K. (2001a). The full-length and N-terminal deletion of ORF2 protein of hepatitis E virus can dimerize. Biochem. Biophys. Res. Commun. 286, 214-221. doi: 10.1006/bbrc.2001.5256
233. Tyagi, S., Jameel, S., and Lal, S. K. (2001b). Self-association and mapping of the interaction domain of hepatitis E virus ORF3 protein. J. Virol. 75, 2493-2498. doi: 10.1128/JVI.75.5.2493-2498.2001
234. Tyagi, S., Korkaya, H., Zafrullah, M., Jameel, S., and Lal, S. K. (2002). The phosphorylated form of the ORF3 protein of hepatitis E virus interacts with its non-glycosylated form of the major capsid protein, ORF2. J. Biol. Chem. 277, 22759-22767. doi: 10.1074/jbc. M200185200
235. Tyagi, S., Surjit, M., and Lal, S. K. (2005). The 41-amino-acid C-terminal region of the hepatitis E virus ORF3 protein interacts with bikunin, a kunitz-type serine protease inhibitor. J. Virol. 79, 12081-12087. doi: 10.1128/JVI.79.18.12081-12087.2005
236. Tyagi, S., Surjit, M., Roy, A. K., Jameel, S., and Lal, S. K. (2004). The ORF3 protein of hepatitis E virus interacts with liver-specific alpha1-microglobulin and its precursor alpha1-microglobulin/bikunin precursor (AMBP) and expedites their export from the hepatocyte. J. Biol. Chem. 279, 29308-29319. doi: 10.1074/jbc. M402017200
237. Tzeng, W. P., Chen, M. H., Derdeyn, C. A., and Frey, T. K. (2001). Rubella virus DI RNAs and replicons: requirement for nonstructural proteins acting in cis for amplification by helper virus. Virology 289, 63-73. doi: 10.1006/viro.2001.1088
238. van den Berg, B., Van Der Eijk, A. A., Pas, S. D., Hunter, J. G., Madden, R. G., Tio-Gillen, A. P., et al. (2014). Guillain-Barre syndrome associated with preceding hepatitis E virus infection. Neurology 82, 491-497. doi: 10.1212/WNL.0000000000000111
239. van der Poel, W. H., Verschoor, F., Van Der Heide, R., Herrera, M. I., Vivo, A., Kooreman, M., et al. (2001). Hepatitis E virus sequences in swine related to sequences in humans, The Netherlands. Emerg. Infect. Dis. 7, 970-976. doi: 10.3201/eid0706.010608
240. van Eijk, J. J., Madden, R. G., Van Der Eijk, A. A., Hunter, J. G., Reimerink, J. H., Bendall, R. P., et al. (2014). Neuralgic amyotrophy and hepatitis E virus infection. Neurology 82, 498-503. doi: 10.1212/WNL.0000000000000112
241. van Kasteren, P. B., Bailey-Elkin, B. A., James, T. W., Ninaber, D. K., Beugeling, C., Khajehpour, M., et al. (2013). Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells. Proc. Natl. Acad. Sci. U.S.A. 110, E838-847. doi: 10.1073/pnas.1218464110
242. Wang, H., Ji, F., Liang, H., Gu, H., Ning, Z., Liu, R., et al. (2015). A proline-rich domain in the genotype 4 hepatitis E virus ORF3 C-terminus is crucial for downstream V105DLP108 immunoactivity. PLoS ONE 10, e0133282. doi: 10.1371/journal.pone.0133282
243. Wang, L., Cao, D., Wei, C., Meng, X. J., Jiang, X., and Tan, M. (2014a). A dual vaccine candidate against norovirus and hepatitis E virus. Vaccine 32, 445-452. doi: 10.1016/j.vaccine.2013.11.064
244. Wang, L., Sun, Y., Du, T., Wang, C., Xiao, S., Mu, Y., et al. (2014b). Identification of an antigenic domain in the N-terminal region of avian hepatitis E virus (HEV) capsid protein that is not common to swine and human HEVs. J. Gen. Virol. 95, 2710-2715. doi: 10.1099/vir.0.069021-0
245. Ward, P., Leblanc, D., Houde, A., and Brassard, J. (2015). Analysis of complete genome sequences and a V239A substitution in the helicase domain of swine hepatitis E virus strains isolated in Canada. Arch. Virol. 160, 1767-1773. doi: 10.1007/s00705-015-2429-8
246. Wedemeyer, H., Pischke, S., and Manns, M. P. (2012). Pathogenesis and treatment of hepatitis e virus infection. Gastroenterology 142, 1388-1397 e1. doi: 10.1053/j.gastro.2012.02.014
247. Wei, S., Walsh, P., Huang, R., and To, S. S. (2000). 93G, a novel sporadic strain of hepatitis E virus in South China isolated by cell culture. J. Med. Virol. 61, 311-318. doi: 10.1002/1096-9071(200007)61:3<311::AID-JMV5>3.0.CO;2-H
248. WHO (2015). Hepatitis E [Online]. Available at: http://www.who.int/mediacentre/factsheets/fs280/en/
249. Woo, P. C., Lau, S. K., Teng, J. L., Tsang, A. K., Joseph, M., Wong, E. Y., et al. (2014). New hepatitis E virus genotype in camels, the Middle East. Emerg. Infect. Dis. 20, 1044-1048. doi: 10.3201/eid2006.140140
250. Worm, H. C., Schlauder, G. G., Wurzer, H., and Mushahwar, I. K. (2000). Identification of a novel variant of hepatitis E virus in Austria: sequence, phylogenetic and serological analysis. J. Gen. Virol. 81, 2885-2890. doi: 10.1099/0022-1317-81-12-2885
251. Xia, M., Wei, C., Wang, L., Cao, D., Meng, X. J., Jiang, X., et al. (2016). Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus. Sci. Rep. 6, 25735. doi: 10.1038/srep25735
252. Xiaofang, L., Zafrullah, M., Ahmad, F., and Jameel, S. (2001). A C-terminal hydrophobic region is required for homo-oligomerization of the hepatitis E virus capsid (ORF2) protein. J. Biomed. Biotechnol. 1, 122-128. doi: 10.1155/S1110724301000262
253. Xing, L., Wang, J. C., Li, T. C., Yasutomi, Y., Lara, J., Khudyakov, Y., et al. (2011). Spatial configuration of hepatitis E virus antigenic domain. J. Virol. 85, 1117-1124. doi: 10.1128/JVI.00657-10
254. Yamada, K., Takahashi, M., Hoshino, Y., Takahashi, H., Ichiyama, K., Nagashima, S., et al. (2009). ORF3 protein of hepatitis E virus is essential for virion release from infected cells. J. Gen. Virol. 90, 1880-1891. doi: 10.1099/vir.0.010561-0
255. Yamashita, T., Mori, Y., Miyazaki, N., Cheng, R. H., Yoshimura, M., Unno, H., et al. (2009). Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc. Natl. Acad. Sci. U.S.A. 106, 12986-12991. doi: 10.1073/pnas.0903699106
256. Yazaki, Y., Mizuo, H., Takahashi, M., Nishizawa, T., Sasaki, N., Gotanda, Y., et al. (2003). Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J. Gen. Virol. 84, 2351-2357. doi: 10.1099/vir.0.19242-0
257. Yin, X., Ambardekar, C., Lu, Y., and Feng, Z. (2016). Distinct entry mechanisms for nonenveloped and quasi-enveloped hepatitis E viruses. J. Virol. 90, 4232-4242. doi: 10.1128/JVI.02804-15
258. Yu, H., Li, S., Yang, C., Wei, M., Song, C., Zheng, Z., et al. (2011). Homology model and potential virus-capsid binding site of a putative HEV receptor Grp78. J. Mol. Model. 17, 987-995. doi: 10.1007/s00894-010-0794-5
259. Zafrullah, M., Ozdener, M. H., Kumar, R., Panda, S. K., and Jameel, S. (1999). Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein. J. Virol. 73, 4074-4082.
260. Zafrullah, M., Ozdener, M. H., Panda, S. K., and Jameel, S. (1997). The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton. J. Virol. 71, 9045-9053.
261. Zarrinpar, A., Bhattacharyya, R. P., and Lim, W. A. (2003). The structure and function of proline recognition domains. Sci. STKE 2003: RE8. doi: 10.1126/stke.2003.179.re8
262. Zeng, W., Xu, M., Liu, S., Sun, L., and Chen, Z. J. (2009). Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. Mol. Cell 36, 315-325. doi: 10.1016/j.molcel.2009.09.037
263. Zhang, M., Purcell, R. H., and Emerson, S. U. (2001). Identification of the 5' terminal sequence of the SAR-55 and MEX-14 strains of hepatitis E virus and confirmation that the genome is capped. J. Med. Virol. 65, 293-295. doi: 10.1002/jmv.2032
264. Zhang, W., Hua, X., Shen, Q., Yang, S., Yin, H., and Cui, L. (2011). Identification of genotype 4 hepatitis E virus binding proteins on swine liver cells. Virol. J. 8, 482. doi: 10.1186/1743-422X-8-482
265. Zhang, Y., Mcatee, P., Yarbough, P. O., Tam, A. W., and Fuerst, T. (1997). Expression, characterization, and immunoreactivities of a soluble hepatitis E virus putative capsid protein species expressed in insect cells. Clin. Diagn. Lab. Immunol. 4, 423-428.
266. Zhang, Y., Zeng, H., Liu, P., Liu, L., Xia, J., Wang, L., et al. (2015). Hepatitis E vaccine immunization for rabbits to prevent animal HEV infection and zoonotic transmission. Vaccine 33, 4922-4928. doi: 10.1016/j.vaccine.2015.07.040
267. Zhao, C., Ma, Z., Harrison, T. J., Feng, R., Zhang, C., Qiao, Z., et al. (2009). A novel genotype of hepatitis E virus prevalent among farmed rabbits in China. J. Med. Virol. 81, 1371-1379. doi: 10.1002/jmv.21536
268. Zheng, Z. Z., Miao, J., Zhao, M., Tang, M., Yeo, A. E., Yu, H., et al. (2010). Role of heat-shock protein 90 in hepatitis E virus capsid trafficking. J. Gen. Virol. 91, 1728-1736. doi: 10.1099/vir.0.019323-0
269. Zhou, Y. H., Purcell, R. H., and Emerson, S. U. (2004). An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4. Vaccine 22, 2578-2585. doi: 10.1016/j.vaccine.2003.12.017
270. Zhu, F. C., Zhang, J., Zhang, X. F., Zhou, C., Wang, Z. Z., Huang, S. J., et al. (2010). Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 376, 895-902. doi: 10.1016/S0140-6736(10)61030-6